Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform
Sign Up to like & getrecommendations! Published in 2025 at "Movement Disorders"
DOI: 10.1002/mds.30190
Abstract: There are currently no disease‐modifying therapies (DMTs) registered for Parkinson's disease (PD). The Edmond J. Safra Accelerating Clinical Trials in Parkinson Disease (EJS ACT‐PD) initiative will expedite clinical assessment of putative DMTs through a multi‐arm… read more here.
Keywords: ejs act; selection prioritization; mams trial; treatment selection ... See more keywords